GERON CORP — Director's Dealing 2010

Jul 13, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GERON CORP (GERN)
CIK: 0000886744
Period of Report: 2010-07-09

Reporting Person: Kelsey Stephen Michael (EVP, CMO, Oncology)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-07-09	Common Stock	A	140000	—	Acquired	216136	Direct
2010-07-09	Common Stock	A	20000	—	Acquired	236136	Direct
2010-07-09	Common Stock	A	20000	—	Acquired	256136	Direct
2010-07-09	Common Stock	A	120000	—	Acquired	376136	Direct

Footnotes

F1: The shares of restricted stock will remain subject to a reacquisition right of Geron over three years until the achievement of certain performance milestone criteria in connection with the Company's imetelstat program.

F2: Includes 2,343 shares acquired under the Geron employee stock purchase plan on June 30, 2010.

F3: The shares of restricted stock will remain subject to a reacquisition right of Geron over three years until the achievement of certain performance milestone criteria in connection with the Company's GRNOPC1 program.

F4: The shares of restricted stock will remain subject to a reacquisition right of Geron over three years until the achievement of certain performance milestone criteria in connection with the Company's strategic initiatives.

F5: The shares of restricted stock will remain subject to a reacquisition right of Geron over three years until the Company's common stock price exceeds certain thresholds.